BREANNE BISHOP: Open Payments
NPI 1699307942 · MOBILE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,516 in 81 payments from 15 companies in 2025. Trend: 2023 $239 · 2024 $129 · 2025 $1,516
Food & beverage: $1,432Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $456 |
| Janssen Biotech, Inc. | 14 | $302 |
| GENZYME CORPORATION | 5 | $133 |
| QOL Medical, LLC | 4 | $95 |
| Lilly USA, LLC | 5 | $93 |
| Ardelyx, Inc. | 5 | $81 |
| PFIZER INC. | 4 | $72 |
| Regeneron Healthcare Solutions, Inc. | 3 | $67 |
| Phathom Pharmaceuticals, Inc. | 5 | $56 |
| Aimmune Therapeutics, Inc. | 3 | $47 |
Products named: TREMFYA, RINVOQ, DUPIXENT, SKYRIZI, Sucraid, OMVOH, IBSRELA, VELSIPITY.
Industry payments across AL — which companies pay providers there.
